Donor	B:C0013018
bone	O
marrow	I:C0005955
cells	I:C0005955
are	O
essential	O
for	O
iNKT	O
cell	I:C2350467
-	O
mediated	O
Foxp3	O
+	O

Donor	O
bone	B:C0005955
marrow	I:C0005955
cells	I:C0005955
are	O
essential	O
for	O
iNKT	O
cell	I:C2350467
-	O
mediated	O
Foxp3	O
+	O

Donor	O
bone	O
marrow	I:C0005955
cells	I:C0005955
are	O
essential	O
for	O
iNKT	B:C2350467
cell	I:C2350467
-	O
mediated	O
Foxp3	O
+	O

Donor	O
bone	O
marrow	I:C0005955
cells	I:C0005955
are	O
essential	O
for	O
iNKT	O
cell	I:C2350467
-	O
mediated	O
Foxp3	B:C1505260
+	O

Treg	B:C0039198
cell	I:C0039198
expansion	O
in	O
a	O
murine	O
model	O
of	O
transplantation	O
tolerance	I:C0887936
.	O

Treg	O
cell	I:C0039198
expansion	B:C0007595
in	O
a	O
murine	O
model	O
of	O
transplantation	O
tolerance	I:C0887936
.	O

Treg	O
cell	I:C0039198
expansion	O
in	O
a	O
murine	B:C0026809
model	O
of	O
transplantation	O
tolerance	I:C0887936
.	O

Treg	O
cell	I:C0039198
expansion	O
in	O
a	O
murine	O
model	B:C0599779
of	O
transplantation	O
tolerance	I:C0887936
.	O

Treg	O
cell	I:C0039198
expansion	O
in	O
a	O
murine	O
model	O
of	O
transplantation	B:C0887936
tolerance	I:C0887936
.	O

Mixed	O
chimerism	O
induction	B:C0017391
is	O
the	O
most	O
reliable	O
method	O
for	O
establishing	O
transplantation	O
tolerance	I:C0887936
.	O

Mixed	O
chimerism	O
induction	O
is	O
the	O
most	O
reliable	O
method	B:C0025663
for	O
establishing	O
transplantation	O
tolerance	I:C0887936
.	O

Mixed	O
chimerism	O
induction	O
is	O
the	O
most	O
reliable	O
method	O
for	O
establishing	O
transplantation	B:C0887936
tolerance	I:C0887936
.	O

We	O
previously	O
described	O
a	O
novel	O
treatment	B:C0087111
using	O
a	O
suboptimal	O
dose	O
of	O
anti-CD40	O
ligand	I:C1254351
(	O
anti-	O
CD40	I:C1254351
ligand	I:C1254351
)	O
and	O
liposomal	O
formulation	O
of	O
a	O
ligand	O
for	O
invariant	O
natural	I:C2350467
killer	I:C2350467
T	I:C2350467
cells	I:C2350467
administered	O
to	O
sub-lethally	O
irradiated	O
recipient	O
mice	I:C0025929
after	O
donor	O
bone	O
marrow	I:C0005955
cell	I:C0005955
(	O
bone	O
marrow	I:C0005955
cell	I:C0005955
)	O
transfer	O
.	O

We	O
previously	O
described	O
a	O
novel	O
treatment	O
using	O
a	O
suboptimal	O
dose	O
of	O
anti-CD40	B:C1254351
ligand	I:C1254351
(	O
anti-	O
CD40	I:C1254351
ligand	I:C1254351
)	O
and	O
liposomal	O
formulation	O
of	O
a	O
ligand	O
for	O
invariant	O
natural	I:C2350467
killer	I:C2350467
T	I:C2350467
cells	I:C2350467
administered	O
to	O
sub-lethally	O
irradiated	O
recipient	O
mice	I:C0025929
after	O
donor	O
bone	O
marrow	I:C0005955
cell	I:C0005955
(	O
bone	O
marrow	I:C0005955
cell	I:C0005955
)	O
transfer	O
.	O

We	O
previously	O
described	O
a	O
novel	O
treatment	O
using	O
a	O
suboptimal	O
dose	O
of	O
anti-CD40	O
ligand	I:C1254351
(	O
anti-	B:C1254351
CD40	I:C1254351
ligand	I:C1254351
)	O
and	O
liposomal	O
formulation	O
of	O
a	O
ligand	O
for	O
invariant	O
natural	I:C2350467
killer	I:C2350467
T	I:C2350467
cells	I:C2350467
administered	O
to	O
sub-lethally	O
irradiated	O
recipient	O
mice	I:C0025929
after	O
donor	O
bone	O
marrow	I:C0005955
cell	I:C0005955
(	O
bone	O
marrow	I:C0005955
cell	I:C0005955
)	O
transfer	O
.	O

We	O
previously	O
described	O
a	O
novel	O
treatment	O
using	O
a	O
suboptimal	O
dose	O
of	O
anti-CD40	O
ligand	I:C1254351
(	O
anti-	O
CD40	I:C1254351
ligand	I:C1254351
)	O
and	O
liposomal	B:C0023828
formulation	O
of	O
a	O
ligand	O
for	O
invariant	O
natural	I:C2350467
killer	I:C2350467
T	I:C2350467
cells	I:C2350467
administered	O
to	O
sub-lethally	O
irradiated	O
recipient	O
mice	I:C0025929
after	O
donor	O
bone	O
marrow	I:C0005955
cell	I:C0005955
(	O
bone	O
marrow	I:C0005955
cell	I:C0005955
)	O
transfer	O
.	O

We	O
previously	O
described	O
a	O
novel	O
treatment	O
using	O
a	O
suboptimal	O
dose	O
of	O
anti-CD40	O
ligand	I:C1254351
(	O
anti-	O
CD40	I:C1254351
ligand	I:C1254351
)	O
and	O
liposomal	O
formulation	B:C0013058
of	O
a	O
ligand	O
for	O
invariant	O
natural	I:C2350467
killer	I:C2350467
T	I:C2350467
cells	I:C2350467
administered	O
to	O
sub-lethally	O
irradiated	O
recipient	O
mice	I:C0025929
after	O
donor	O
bone	O
marrow	I:C0005955
cell	I:C0005955
(	O
bone	O
marrow	I:C0005955
cell	I:C0005955
)	O
transfer	O
.	O

We	O
previously	O
described	O
a	O
novel	O
treatment	O
using	O
a	O
suboptimal	O
dose	O
of	O
anti-CD40	O
ligand	I:C1254351
(	O
anti-	O
CD40	I:C1254351
ligand	I:C1254351
)	O
and	O
liposomal	O
formulation	O
of	O
a	O
ligand	O
for	O
invariant	B:C2350467
natural	I:C2350467
killer	I:C2350467
T	I:C2350467
cells	I:C2350467
administered	O
to	O
sub-lethally	O
irradiated	O
recipient	O
mice	I:C0025929
after	O
donor	O
bone	O
marrow	I:C0005955
cell	I:C0005955
(	O
bone	O
marrow	I:C0005955
cell	I:C0005955
)	O
transfer	O
.	O

We	O
previously	O
described	O
a	O
novel	O
treatment	O
using	O
a	O
suboptimal	O
dose	O
of	O
anti-CD40	O
ligand	I:C1254351
(	O
anti-	O
CD40	I:C1254351
ligand	I:C1254351
)	O
and	O
liposomal	O
formulation	O
of	O
a	O
ligand	O
for	O
invariant	O
natural	I:C2350467
killer	I:C2350467
T	I:C2350467
cells	I:C2350467
administered	O
to	O
sub-lethally	B:C0243095
irradiated	O
recipient	O
mice	I:C0025929
after	O
donor	O
bone	O
marrow	I:C0005955
cell	I:C0005955
(	O
bone	O
marrow	I:C0005955
cell	I:C0005955
)	O
transfer	O
.	O

We	O
previously	O
described	O
a	O
novel	O
treatment	O
using	O
a	O
suboptimal	O
dose	O
of	O
anti-CD40	O
ligand	I:C1254351
(	O
anti-	O
CD40	I:C1254351
ligand	I:C1254351
)	O
and	O
liposomal	O
formulation	O
of	O
a	O
ligand	O
for	O
invariant	O
natural	I:C2350467
killer	I:C2350467
T	I:C2350467
cells	I:C2350467
administered	O
to	O
sub-lethally	O
irradiated	O
recipient	B:C0025929
mice	I:C0025929
after	O
donor	O
bone	O
marrow	I:C0005955
cell	I:C0005955
(	O
bone	O
marrow	I:C0005955
cell	I:C0005955
)	O
transfer	O
.	O

We	O
previously	O
described	O
a	O
novel	O
treatment	O
using	O
a	O
suboptimal	O
dose	O
of	O
anti-CD40	O
ligand	I:C1254351
(	O
anti-	O
CD40	I:C1254351
ligand	I:C1254351
)	O
and	O
liposomal	O
formulation	O
of	O
a	O
ligand	O
for	O
invariant	O
natural	I:C2350467
killer	I:C2350467
T	I:C2350467
cells	I:C2350467
administered	O
to	O
sub-lethally	O
irradiated	O
recipient	O
mice	I:C0025929
after	O
donor	B:C0013018
bone	O
marrow	I:C0005955
cell	I:C0005955
(	O
bone	O
marrow	I:C0005955
cell	I:C0005955
)	O
transfer	O
.	O

We	O
previously	O
described	O
a	O
novel	O
treatment	O
using	O
a	O
suboptimal	O
dose	O
of	O
anti-CD40	O
ligand	I:C1254351
(	O
anti-	O
CD40	I:C1254351
ligand	I:C1254351
)	O
and	O
liposomal	O
formulation	O
of	O
a	O
ligand	O
for	O
invariant	O
natural	I:C2350467
killer	I:C2350467
T	I:C2350467
cells	I:C2350467
administered	O
to	O
sub-lethally	O
irradiated	O
recipient	O
mice	I:C0025929
after	O
donor	O
bone	B:C0005955
marrow	I:C0005955
cell	I:C0005955
(	O
bone	O
marrow	I:C0005955
cell	I:C0005955
)	O
transfer	O
.	O

We	O
previously	O
described	O
a	O
novel	O
treatment	O
using	O
a	O
suboptimal	O
dose	O
of	O
anti-CD40	O
ligand	I:C1254351
(	O
anti-	O
CD40	I:C1254351
ligand	I:C1254351
)	O
and	O
liposomal	O
formulation	O
of	O
a	O
ligand	O
for	O
invariant	O
natural	I:C2350467
killer	I:C2350467
T	I:C2350467
cells	I:C2350467
administered	O
to	O
sub-lethally	O
irradiated	O
recipient	O
mice	I:C0025929
after	O
donor	O
bone	O
marrow	I:C0005955
cell	I:C0005955
(	O
bone	B:C0005955
marrow	I:C0005955
cell	I:C0005955
)	O
transfer	O
.	O

We	O
previously	O
described	O
a	O
novel	O
treatment	O
using	O
a	O
suboptimal	O
dose	O
of	O
anti-CD40	O
ligand	I:C1254351
(	O
anti-	O
CD40	I:C1254351
ligand	I:C1254351
)	O
and	O
liposomal	O
formulation	O
of	O
a	O
ligand	O
for	O
invariant	O
natural	I:C2350467
killer	I:C2350467
T	I:C2350467
cells	I:C2350467
administered	O
to	O
sub-lethally	O
irradiated	O
recipient	O
mice	I:C0025929
after	O
donor	O
bone	O
marrow	I:C0005955
cell	I:C0005955
(	O
bone	O
marrow	I:C0005955
cell	I:C0005955
)	O
transfer	B:C0040732
.	O

Recipient	B:C0025929
mice	I:C0025929
treated	O
with	I:C0332293
this	O
regimen	O
showed	O
expansion	O
of	O
a	O
Foxp3	O
-	O
positive	O
regulatory	O
T(	I:C0039198
Treg	I:C0039198
)	I:C0039198
cell	I:C0039198
phenotype	O
,	O
and	O
formation	O
of	O
mixed	O
chimera	O
.	O

Recipient	O
mice	I:C0025929
treated	B:C0332293
with	I:C0332293
this	O
regimen	O
showed	O
expansion	O
of	O
a	O
Foxp3	O
-	O
positive	O
regulatory	O
T(	I:C0039198
Treg	I:C0039198
)	I:C0039198
cell	I:C0039198
phenotype	O
,	O
and	O
formation	O
of	O
mixed	O
chimera	O
.	O

Recipient	O
mice	I:C0025929
treated	O
with	I:C0332293
this	O
regimen	B:C0040808
showed	O
expansion	O
of	O
a	O
Foxp3	O
-	O
positive	O
regulatory	O
T(	I:C0039198
Treg	I:C0039198
)	I:C0039198
cell	I:C0039198
phenotype	O
,	O
and	O
formation	O
of	O
mixed	O
chimera	O
.	O

Recipient	O
mice	I:C0025929
treated	O
with	I:C0332293
this	O
regimen	O
showed	O
expansion	B:C0007595
of	O
a	O
Foxp3	O
-	O
positive	O
regulatory	O
T(	I:C0039198
Treg	I:C0039198
)	I:C0039198
cell	I:C0039198
phenotype	O
,	O
and	O
formation	O
of	O
mixed	O
chimera	O
.	O

Recipient	O
mice	I:C0025929
treated	O
with	I:C0332293
this	O
regimen	O
showed	O
expansion	O
of	O
a	O
Foxp3	B:C1505260
-	O
positive	O
regulatory	O
T(	I:C0039198
Treg	I:C0039198
)	I:C0039198
cell	I:C0039198
phenotype	O
,	O
and	O
formation	O
of	O
mixed	O
chimera	O
.	O

Recipient	O
mice	I:C0025929
treated	O
with	I:C0332293
this	O
regimen	O
showed	O
expansion	O
of	O
a	O
Foxp3	O
-	O
positive	O
regulatory	B:C0039198
T(	I:C0039198
Treg	I:C0039198
)	I:C0039198
cell	I:C0039198
phenotype	O
,	O
and	O
formation	O
of	O
mixed	O
chimera	O
.	O

However	O
,	O
the	O
mechanism	B:C0007613
of	O
expansion	O
and	O
bioactivity	O
of	O
Treg	O
cells	I:C0039198
remains	O
unclear	O
.	O

However	O
,	O
the	O
mechanism	O
of	O
expansion	B:C0007595
and	O
bioactivity	O
of	O
Treg	O
cells	I:C0039198
remains	O
unclear	O
.	O

However	O
,	O
the	O
mechanism	O
of	O
expansion	O
and	O
bioactivity	O
of	O
Treg	B:C0039198
cells	I:C0039198
remains	O
unclear	O
.	O

Here	O
,	O
we	O
examine	B:C0332128
the	O
role	O
of	O
donor	O
BMCs	O
in	O
the	O
expansion	O
of	O
bioactive	O
Treg	O
cells	I:C0039198
.	O

Here	O
,	O
we	O
examine	O
the	O
role	O
of	O
donor	B:C0013018
BMCs	O
in	O
the	O
expansion	O
of	O
bioactive	O
Treg	O
cells	I:C0039198
.	O

Here	O
,	O
we	O
examine	O
the	O
role	O
of	O
donor	O
BMCs	B:C0005955
in	O
the	O
expansion	O
of	O
bioactive	O
Treg	O
cells	I:C0039198
.	O

Here	O
,	O
we	O
examine	O
the	O
role	O
of	O
donor	O
BMCs	O
in	O
the	O
expansion	B:C0007595
of	O
bioactive	O
Treg	O
cells	I:C0039198
.	O

Here	O
,	O
we	O
examine	O
the	O
role	O
of	O
donor	O
BMCs	O
in	O
the	O
expansion	O
of	O
bioactive	O
Treg	B:C0039198
cells	I:C0039198
.	O

The	O
mouse	B:C2986594
model	I:C2986594
was	O
transplanted	O
with	O
a	O
heart	O
allograft	I:C0564471
the	O
day	O
after	O
treatment	O
.	O

The	O
mouse	O
model	I:C2986594
was	O
transplanted	B:C0040732
with	O
a	O
heart	O
allograft	I:C0564471
the	O
day	O
after	O
treatment	O
.	O

The	O
mouse	O
model	I:C2986594
was	O
transplanted	O
with	O
a	O
heart	B:C0564471
allograft	I:C0564471
the	O
day	O
after	O
treatment	O
.	O

The	O
mouse	O
model	I:C2986594
was	O
transplanted	O
with	O
a	O
heart	O
allograft	I:C0564471
the	O
day	O
after	O
treatment	B:C0087111
.	O

The	O
results	O
showed	O
that	O
transfer	B:C0040732
of	O
spleen	O
cells	O
in	O
place	O
of	O
BMCs	O
failed	O
to	O
deplete	O
host	O
interferon	O
(	I:C3539881
IFN	I:C3539881
)	I:C3539881
-γ	I:C3539881
-	O
producing	O
CD8	O
(	I:C0242629
+	I:C0242629
)	I:C0242629

The	O
results	O
showed	O
that	O
transfer	O
of	O
spleen	B:C0037993
cells	O
in	O
place	O
of	O
BMCs	O
failed	O
to	O
deplete	O
host	O
interferon	O
(	I:C3539881
IFN	I:C3539881
)	I:C3539881
-γ	I:C3539881
-	O
producing	O
CD8	O
(	I:C0242629
+	I:C0242629
)	I:C0242629

The	O
results	O
showed	O
that	O
transfer	O
of	O
spleen	O
cells	B:C0007634
in	O
place	O
of	O
BMCs	O
failed	O
to	O
deplete	O
host	O
interferon	O
(	I:C3539881
IFN	I:C3539881
)	I:C3539881
-γ	I:C3539881
-	O
producing	O
CD8	O
(	I:C0242629
+	I:C0242629
)	I:C0242629

The	O
results	O
showed	O
that	O
transfer	O
of	O
spleen	O
cells	O
in	O
place	O
of	O
BMCs	B:C0005955
failed	O
to	O
deplete	O
host	O
interferon	O
(	I:C3539881
IFN	I:C3539881
)	I:C3539881
-γ	I:C3539881
-	O
producing	O
CD8	O
(	I:C0242629
+	I:C0242629
)	I:C0242629

The	O
results	O
showed	O
that	O
transfer	O
of	O
spleen	O
cells	O
in	O
place	O
of	O
BMCs	O
failed	O
to	O
deplete	O
host	B:C1819995
interferon	O
(	I:C3539881
IFN	I:C3539881
)	I:C3539881
-γ	I:C3539881
-	O
producing	O
CD8	O
(	I:C0242629
+	I:C0242629
)	I:C0242629

The	O
results	O
showed	O
that	O
transfer	O
of	O
spleen	O
cells	O
in	O
place	O
of	O
BMCs	O
failed	O
to	O
deplete	O
host	O
interferon	B:C3539881
(	I:C3539881
IFN	I:C3539881
)	I:C3539881
-γ	I:C3539881
-	O
producing	O
CD8	O
(	I:C0242629
+	I:C0242629
)	I:C0242629

The	O
results	O
showed	O
that	O
transfer	O
of	O
spleen	O
cells	O
in	O
place	O
of	O
BMCs	O
failed	O
to	O
deplete	O
host	O
interferon	O
(	I:C3539881
IFN	I:C3539881
)	I:C3539881
-γ	I:C3539881
-	O
producing	O
CD8	B:C0242629
(	I:C0242629
+	I:C0242629
)	I:C0242629

T	I:C0242629
cells	I:C0242629
,	O
expand	O
host	B:C1819995
Ki67(+	O
)	I:C0039198
CD4	I:C0039198
(+)	I:C0039198
CD25	I:C0039198
(+)	I:C0039198
Foxp3	I:C0039198
(+)	I:C0039198

T	I:C0242629
cells	I:C0242629
,	O
expand	O
host	O
Ki67(+	B:C0039198
)	I:C0039198
CD4	I:C0039198
(+)	I:C0039198
CD25	I:C0039198
(+)	I:C0039198
Foxp3	I:C0039198
(+)	I:C0039198

Treg	I:C0039198
cells	I:C0039198
,	O
and	O
prolong	O
graft	B:C0018131
survival	I:C0018131
.	O

Severe	O
combined	O
immunodeficiency	B:C0021051
mice	O
who	O
received	O
Treg	O
cells	I:C0039198
obtained	O
from	O
BMC	O
-	O
recipients	O
accepted	O
skin	O
grafts	I:C0181078
in	O
an	O
allo	O
-	O
specific	O
manner	O
.	O

Severe	O
combined	O
immunodeficiency	O
mice	B:C0025929
who	O
received	O
Treg	O
cells	I:C0039198
obtained	O
from	O
BMC	O
-	O
recipients	O
accepted	O
skin	O
grafts	I:C0181078
in	O
an	O
allo	O
-	O
specific	O
manner	O
.	O

Severe	O
combined	O
immunodeficiency	O
mice	O
who	O
received	O
Treg	B:C0039198
cells	I:C0039198
obtained	O
from	O
BMC	O
-	O
recipients	O
accepted	O
skin	O
grafts	I:C0181078
in	O
an	O
allo	O
-	O
specific	O
manner	O
.	O

Severe	O
combined	O
immunodeficiency	O
mice	O
who	O
received	O
Treg	O
cells	I:C0039198
obtained	O
from	O
BMC	O
-	O
recipients	O
accepted	O
skin	B:C0181078
grafts	I:C0181078
in	O
an	O
allo	O
-	O
specific	O
manner	O
.	O

Myeloid	B:C4277543
-	I:C4277543
derived	I:C4277543
suppressor	I:C4277543
cells	I:C4277543
,	O
which	O
were	O
a	O
copious	O
cell	I:C0007634
subset	I:C0007634
in	O
BMCs	O
,	O
enhanced	O
the	O
Ki67	O
expression	O
of	O
Treg	O
cells	I:C0039198
.	O

Myeloid	O
-	I:C4277543
derived	I:C4277543
suppressor	I:C4277543
cells	I:C4277543
,	O
which	O
were	O
a	O
copious	B:C0007634
cell	I:C0007634
subset	I:C0007634
in	O
BMCs	O
,	O
enhanced	O
the	O
Ki67	O
expression	O
of	O
Treg	O
cells	I:C0039198
.	O

Myeloid	O
-	I:C4277543
derived	I:C4277543
suppressor	I:C4277543
cells	I:C4277543
,	O
which	O
were	O
a	O
copious	O
cell	I:C0007634
subset	I:C0007634
in	O
BMCs	B:C0005955
,	O
enhanced	O
the	O
Ki67	O
expression	O
of	O
Treg	O
cells	I:C0039198
.	O

Myeloid	O
-	I:C4277543
derived	I:C4277543
suppressor	I:C4277543
cells	I:C4277543
,	O
which	O
were	O
a	O
copious	O
cell	I:C0007634
subset	I:C0007634
in	O
BMCs	O
,	O
enhanced	O
the	O
Ki67	B:C0208804
expression	O
of	O
Treg	O
cells	I:C0039198
.	O

Myeloid	O
-	I:C4277543
derived	I:C4277543
suppressor	I:C4277543
cells	I:C4277543
,	O
which	O
were	O
a	O
copious	O
cell	I:C0007634
subset	I:C0007634
in	O
BMCs	O
,	O
enhanced	O
the	O
Ki67	O
expression	B:C1171362
of	O
Treg	O
cells	I:C0039198
.	O

Myeloid	O
-	I:C4277543
derived	I:C4277543
suppressor	I:C4277543
cells	I:C4277543
,	O
which	O
were	O
a	O
copious	O
cell	I:C0007634
subset	I:C0007634
in	O
BMCs	O
,	O
enhanced	O
the	O
Ki67	O
expression	O
of	O
Treg	B:C0039198
cells	I:C0039198
.	O

This	O
suggests	O
that	O
donor	B:C0013018
BMCs	O
are	O
indispensable	O
for	O
the	O
expansion	O
of	O
host	O
bioactive	O
Treg	O
cells	I:C0039198
in	O
our	O
novel	O
treatment	O
for	O
transplant	O
tolerance	I:C1817969
induction	I:C1817969
.	O

This	O
suggests	O
that	O
donor	O
BMCs	B:C0005955
are	O
indispensable	O
for	O
the	O
expansion	O
of	O
host	O
bioactive	O
Treg	O
cells	I:C0039198
in	O
our	O
novel	O
treatment	O
for	O
transplant	O
tolerance	I:C1817969
induction	I:C1817969
.	O

This	O
suggests	O
that	O
donor	O
BMCs	O
are	O
indispensable	O
for	O
the	O
expansion	B:C0007595
of	O
host	O
bioactive	O
Treg	O
cells	I:C0039198
in	O
our	O
novel	O
treatment	O
for	O
transplant	O
tolerance	I:C1817969
induction	I:C1817969
.	O

This	O
suggests	O
that	O
donor	O
BMCs	O
are	O
indispensable	O
for	O
the	O
expansion	O
of	O
host	B:C1819995
bioactive	O
Treg	O
cells	I:C0039198
in	O
our	O
novel	O
treatment	O
for	O
transplant	O
tolerance	I:C1817969
induction	I:C1817969
.	O

This	O
suggests	O
that	O
donor	O
BMCs	O
are	O
indispensable	O
for	O
the	O
expansion	O
of	O
host	O
bioactive	O
Treg	B:C0039198
cells	I:C0039198
in	O
our	O
novel	O
treatment	O
for	O
transplant	O
tolerance	I:C1817969
induction	I:C1817969
.	O

This	O
suggests	O
that	O
donor	O
BMCs	O
are	O
indispensable	O
for	O
the	O
expansion	O
of	O
host	O
bioactive	O
Treg	O
cells	I:C0039198
in	O
our	O
novel	O
treatment	B:C0087111
for	O
transplant	O
tolerance	I:C1817969
induction	I:C1817969
.	O

This	O
suggests	O
that	O
donor	O
BMCs	O
are	O
indispensable	O
for	O
the	O
expansion	O
of	O
host	O
bioactive	O
Treg	O
cells	I:C0039198
in	O
our	O
novel	O
treatment	O
for	O
transplant	B:C1817969
tolerance	I:C1817969
induction	I:C1817969
.	O

